Clinical Trial Update: Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome [Phase 2]

View source ↗

Summary

Update on a Phase 2 clinical trial evaluating a combination of clomiphene citrate and cabergoline for polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Clomid (clomiphene citrate)
• Dostinex (cabergoline)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Female Reproductive Problem | Phase 2 | Status: UNKNOWN